CURRENT TOPICS IN MEDICINAL CHEMISTRY
Scope & Guideline
Leading the Way in Medicinal Chemistry Research
Introduction
Aims and Scopes
- Synthesis of Bioactive Compounds:
The journal covers research focused on the development and synthesis of novel bioactive compounds, including small molecules, natural products, and hybrid structures that hold therapeutic potential. - Drug Discovery and Development:
Emphasizing the drug discovery process, the journal includes studies that explore the mechanisms of action, efficacy, and safety profiles of new and existing compounds against various diseases. - Computational and Structural Biology:
There is a strong emphasis on computational approaches, such as molecular docking and QSAR modeling, to predict the efficacy of drug candidates and to understand their interactions at the molecular level. - Pharmacology and Therapeutics:
Research published in the journal often includes pharmacological studies that investigate the therapeutic effects of compounds, their mechanisms of action, and potential clinical applications. - Natural Products and Traditional Medicine:
The journal frequently highlights studies on natural products derived from plants and other organisms, exploring their pharmacological properties and potential as alternatives to conventional therapies. - Multitarget Drug Approaches:
A notable focus is placed on the development of multitarget drugs that can address complex diseases such as cancer and neurodegenerative disorders, enhancing therapeutic efficacy and reducing side effects.
Trending and Emerging
- Nanotechnology in Drug Delivery:
Research on nanotechnology applications in drug delivery systems is rapidly increasing, highlighting the potential of nanocarriers to enhance the bioavailability and efficacy of therapeutic agents. - Artificial Intelligence in Drug Discovery:
The integration of artificial intelligence and machine learning techniques in drug discovery processes is becoming a prominent theme, offering new avenues for compound design, optimization, and predictive modeling. - Immunotherapy and Targeted Therapies:
There is a growing interest in immunotherapeutic strategies and targeted therapies, particularly in oncology, where researchers are exploring ways to enhance the immune response against tumors. - Natural Products as Drug Candidates:
The resurgence of interest in natural products and phytochemicals as potential drug candidates is evident, with a focus on their multifaceted biological activities and mechanisms of action. - Microbiome and Drug Interactions:
Research exploring the interaction between the microbiome and pharmacotherapy is emerging, emphasizing the importance of understanding how gut microbiota can influence drug metabolism and efficacy. - Sustainable and Green Chemistry Practices:
The journal is increasingly featuring studies on sustainable and environmentally friendly synthetic methodologies, reflecting a broader commitment to reducing the ecological impact of drug development.
Declining or Waning
- Traditional Antibacterial Agents:
Research focusing solely on conventional antibacterial agents has decreased, likely due to the rising interest in novel antimicrobial strategies, including the use of natural products and hybrid compounds. - Single-target Drug Design:
There is a noticeable decline in studies centered on single-target drug design, as the field shifts towards a more integrated approach that considers multitarget strategies and polypharmacology. - Basic Research on Established Drugs:
The journal has seen fewer submissions related to the basic pharmacological research of established drugs, which may be overshadowed by the exploration of new compounds and innovative therapeutic approaches. - Chemical Modifications of Well-known Scaffolds:
The focus on minor chemical modifications of well-characterized scaffolds appears to be waning, as researchers are increasingly interested in discovering new scaffolds with novel mechanisms of action. - Synthetic Methodologies for Known Compounds:
There has been a reduction in publications dedicated to the synthesis of already well-studied compounds, with a stronger emphasis now on developing new synthetic strategies and methodologies.
Similar Journals
Medicinal Chemistry
Catalyzing breakthroughs in drug formulation and discovery.Medicinal Chemistry is a prestigious journal published by Bentham Science Publishers Ltd, dedicated to advancing the field of drug discovery and development. Established in 2005 with a converged publication timeframe extending to 2024, this journal serves as a vital resource for researchers and professionals interested in the intricate processes of medicinal chemistry, pharmacology, and toxicology. With an ISSN of 1573-4064 and an E-ISSN of 1875-6638, it has established a notable presence in the academic community, currently positioned in Q3 of Drug Discovery category according to the 2023 quartiles. The journal's ranking in Scopus places it at 90 out of 157 in its field, showcasing its impact and relevance, with a percentile standing of 42. Although the journal is not open access, it continues to provide insightful articles and research findings that contribute significantly to the understanding and innovation in medicinal chemistry. Based in the United Arab Emirates, Medicinal Chemistry is committed to disseminating high-quality research that shapes the future of drug formulation and therapeutic advancement.
MINI-REVIEWS IN MEDICINAL CHEMISTRY
Advancing the Frontiers of Drug Discovery.MINI-REVIEWS IN MEDICINAL CHEMISTRY is a distinguished journal published by Bentham Science Publishers, dedicated to the cutting-edge field of medicinal chemistry. With an ISSN of 1389-5575 and an E-ISSN of 1875-5607, this journal serves as an essential platform for researchers and professionals to disseminate concise yet comprehensive reviews that capture the latest advancements and trends in drug discovery, cancer research, pharmacology, and molecular medicine. Operating since 2001, it has consistently maintained a relevant presence in academia with its impressive rank metrics, including a Q2 category in Drug Discovery and Pharmacology in 2023, highlighting its significance in the scientific community. The journal is recognized for its rigorous peer-review process and provides an invaluable resource for students and researchers seeking insights into the rapidly evolving landscape of medicinal chemistry. With a commitment to excellence and innovation, MINI-REVIEWS IN MEDICINAL CHEMISTRY continues to foster knowledge exchange and inspire future breakthroughs in healthcare and therapeutic advancements.
Chemical Biology & Drug Design
Innovating at the crossroads of science and therapeutic applications.Chemical Biology & Drug Design, an esteemed publication by WILEY, serves as a vital platform for the dissemination of pioneering research in the interdisciplinary fields of biochemistry, drug discovery, molecular medicine, organic chemistry, and pharmacology. With a dedicated commitment to advancing the understanding of chemical interactions and drug development, this journal not only fosters innovation but also bridges the gap between theoretical research and practical applications. It boasts an impressive impact factor and is recognized in the 2023 category quartiles as Q3 in Biochemistry and Molecular Medicine, and Q2 in Drug Discovery, Organic Chemistry, and Pharmacology, indicating its relevance and influence in these crucial areas. The journal’s rankings across various Scopus categories further solidify its position as a reputable resource for researchers, professionals, and students striving to stay at the forefront of medicinal chemistry and drug design. While primarily traditional access-based, the journal's evolving scope from 2006 to 2024 ensures an ongoing contribution to essential scientific dialogue, making it an indispensable read for those committed to advancing health sciences.
Drug Research
Pioneering Insights for Future TherapiesDrug Research, published by GEORG THIEME VERLAG KG, is a pivotal journal housed in the vibrant realm of pharmacology and drug discovery. With a commitment to advancing the understanding of medicinal substances, this journal serves as an essential resource for researchers, professionals, and students dedicated to the field. The journal boasts an ISSN of 2194-9379 and an E-ISSN of 2194-9387, reflecting its dual commitment to print and digital accessibility. Despite its status as a Q3 journal in both Drug Discovery and Miscellaneous Medicine categories as of 2023, it continues to offer valuable insights with a focus on the latest innovations, methodologies, and findings in drug research. Based in Germany, Drug Research promotes scholarly communication and collaboration within the scientific community, ensuring that its contributions remain impactful in shaping future therapeutic discoveries. The journal is indexed in relevant databases, enhancing its visibility and reach, thus fostering a robust academic dialogue.
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS
Pioneering research for a healthier tomorrow.BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, published by PERGAMON-ELSEVIER SCIENCE LTD, is a leading journal in the fields of biochemistry, drug discovery, and medicinal chemistry, designed to disseminate significant advances in these disciplines. Established in 1991, the journal spans various important categories, including Organic Chemistry and Pharmaceutical Science, with its 2023 Scimago Journal Rank placing it at Q2 in Organic Chemistry and Q3 in several other relevant fields. Though not an open-access publication, it provides invaluable insights into contemporary research and innovative methodologies, appealing to researchers, professionals, and students alike. The journal's commitment to quality and relevance makes it a vital resource for those aiming to stay at the forefront of bioorganic and medicinal chemistry developments. For more information, please visit the journal's website as it remains a critical platform for scholarly exchange, particularly for those engaged in interdisciplinary research.
Advances in Pharmacological and Pharmaceutical Sciences
Empowering Global Collaboration in Pharmacology.Advances in Pharmacological and Pharmaceutical Sciences is a premier open-access journal published by Hindawi Ltd. based in the United Kingdom. Established in 2020, the journal swiftly garnered attention for its commitment to disseminating high-quality research in the realms of pharmacology, toxicology, and pharmaceutical sciences. It holds a commendable impact with notable quartile rankings, including Q2 in both Organic Chemistry and Pharmacology, indicating its importance within these disciplines. By embracing an open-access model, the journal ensures that research findings are widely available, promoting increased visibility and collaboration among researchers, professionals, and students globally. With an ongoing convergence of insights projected through 2024, Advances in Pharmacological and Pharmaceutical Sciences aims to address critical issues and advancements in drug development and therapeutic practices, making it an invaluable resource for those at the forefront of scientific inquiry in pharmacology and related fields.
European Journal of Medicinal Chemistry Reports
Bridging the gap between lab research and real-world applications.European Journal of Medicinal Chemistry Reports, published by ELSEVIER, is a vital platform dedicated to advancing the field of medicinal chemistry through open access communication of high-quality research. With an impact factor reflecting its growing influence, this journal has rapidly established a reputation for scholarly excellence since its launch in 2021. It serves as a converging point for innovative studies and reviews that span the disciplines of chemistry and molecular medicine, reflected in its Q2 and Q3 quartile rankings in relevant categories for 2023. Situated in France, the journal is accessible globally, ensuring that researchers, professionals, and students can easily engage with significant findings and methodologies in medicinal chemistry. The open access model facilitates the dissemination of knowledge, bridging gaps between laboratory research and practical applications in drug development. By fostering collaboration and highlighting emerging trends, the European Journal of Medicinal Chemistry Reports plays a crucial role in shaping the future of therapeutic innovations.
Records of Natural Products
Advancing Discoveries in Natural Product ScienceRecords of Natural Products is a distinguished journal focused on the dynamic fields of Drug Discovery, Organic Chemistry, Pharmacology, and Plant Science. Published by ACG PUBLICATIONS in Turkey, this journal serves as a vital platform for disseminating innovative research findings and advancements in natural product studies. With its convergence spanning from 2009 to 2024, Records of Natural Products holds a commendable position in the academic realm, featuring a 2023 Q3 ranking in Drug Discovery and Organic Chemistry, alongside a notable Q2 ranking in Plant Science. Despite its current lack of open access, the journal is committed to providing quality content that enriches the understanding of natural products and their potential applications. Researchers and professionals alike can benefit from the journal's insights, which not only contribute to scientific knowledge but also facilitate advancements in pharmaceuticals and sustainable practices. By exploring the rich tapestry of natural product research, this journal underscores its importance as a leading resource for professionals dedicated to enhancing the efficacy and application of natural compounds.
EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
Shaping Therapeutic Strategies with High-Quality Research.European Journal of Medicinal Chemistry, a premier publication by Elsevier France-Editions Scientifiques Médicales Elsevier, has been at the forefront of advancing medicinal chemistry since its inception in 1974. With an impressive impact factor and ranking in the Q1 quartile across multiple categories including Drug Discovery, Medicine (miscellaneous), Organic Chemistry, and Pharmacology, this journal delivers cutting-edge research and reviews that are vital for researchers and professionals in the field. The journal’s scope encompasses the design, synthesis, and evaluation of biological activity of bioactive compounds, making it a critical resource for those looking to innovate in drug development and therapeutic strategies. Although currently not open access, subscribers can benefit from its diverse range of high-quality articles, ensuring the dissemination of knowledge in the ever-evolving landscape of medicinal chemistry. The European Journal of Medicinal Chemistry continues to play a pivotal role in shaping the future of pharmacological research and its application, thus appealing to an audience dedicated to making impactful scientific contributions.
Current Computer-Aided Drug Design
Pioneering Computational Strategies for Effective Drug DesignCurrent Computer-Aided Drug Design, published by BENTHAM SCIENCE PUBL LTD, is a pivotal journal dedicated to the integration of computer-aided methodologies within the drug design process. With its ISSN 1573-4099 and E-ISSN 1875-6697, this journal serves as a vital resource for researchers, professionals, and students interested in advancing the fields of pharmacology and molecular medicine. Operating under a framework that spans from 2006 to 2024, it aims to foster innovative approaches and discussions surrounding drug design strategies, computational techniques, and the therapeutic potential of novel compounds. Although it currently holds a Q4 rating in Drug Discovery and Molecular Medicine as well as a Q3 in Medicine (miscellaneous) within the 2023 category quartiles, the journal continues to enhance its visibility and relevance in the academic community. Its Scopus rankings reflect its commitment to quality research, positioning it in the context of drug discovery and molecular studies. As the field of drug design evolves, Current Computer-Aided Drug Design remains an essential platform for disseminating cutting-edge findings and facilitating collaboration among specialists aiming for significant advancements in drug development.